ESRRA and colorectal carcinoma: Altogether, the findings of earlier studies suggest that ERRα could have oncogenic activities in CRC cells and suppressing its expression alone or combined with treatment with MEK inhibitor could represent promising efficient therapeutic strategies against CRC [107].